DELILAH FRANCO: Open Payments
NPI 1336560820 · EL PASO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$632 in 24 payments from 11 companies in 2025. Trend: 2023 $913 · 2024 $406 · 2025 $632
Food & beverage: $632
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $177 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $109 |
| AstraZeneca Pharmaceuticals LP | 1 | $102 |
| Boston Scientific Corporation | 1 | $91 |
| Exact Sciences Corporation | 3 | $54 |
| Amgen Inc. | 1 | $21 |
| Abbott Laboratories | 1 | $20 |
| Lilly USA, LLC | 1 | $16 |
| Novo Nordisk Inc | 1 | $16 |
| GlaxoSmithKline, LLC. | 1 | $14 |
Products named: BOTOX, Kerendia, FARXIGA, FARAPULSE, The Cologuard Plus Collection Kit, QULIPTA, OTEZLA, FREESTYLE LIBRE 3.
Industry payments across TX — which companies pay providers there.
